Sarepta Therapeutics Inc

Company Snapshot
215 First Street
Cambridge, MA 02142
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 1,372
https://www.sarepta.com
Please select from the dropdown
  1. Executive Compensation
  2. > Sarepta Therapeutics Inc
Company Financials

2022
2023
2024
Gross Profit
$793,024,000
$1,092,993,000
$1,582,880,000
Operating Income
-$536,201,000
-$267,824,000
$218,081,000
Net Income
-$703,488,000
-$535,977,000
$235,239,000
2022
Gross Profit
$793,024,000
Operating Income
-$536,201,000
Net Income
-$703,488,000
2023
Gross Profit
$1,092,993,000
Operating Income
-$267,824,000
Net Income
-$535,977,000
2024
Gross Profit
$1,582,880,000
Operating Income
$218,081,000
Net Income
$235,239,000
The above data on Sarepta Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Louise Rodino-Klapac
Executive Vice President Head of R&D and Chief Scientific Officer
$1,012,421
$2,690,864
$15,706
$3,718,991
Louise Rodino-Klapac
$3,718,991
Executive Vice President Head of R&D and Chief Scientific Officer
Ian Estepan
Executive Vice President Chief Financial Officer and Principal Accounting Officer
$984,441
$2,690,864
$30,321
$3,705,626
Ian Estepan
$3,705,626
Executive Vice President Chief Financial Officer and Principal Accounting Officer
Ryan Brown
Executive Vice President General Counsel and Corporate Secretary
$871,617
$2,690,864
$15,850
$3,578,331
Ryan Brown
$3,578,331
Executive Vice President General Counsel and Corporate Secretary
Bilal Arif
Executive Vice President and Chief Technical Operations Officer
$813,112
$2,690,864
$16,611
$3,520,587
Bilal Arif
$3,520,587
Executive Vice President and Chief Technical Operations Officer
Douglas Ingram
Director, President and Chief Executive Officer
$1,642,316
$0
$19,022
$1,661,338
Douglas Ingram
$1,661,338
Director, President and Chief Executive Officer
Sarepta Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us